Company intelligence / Profile preview

The Mind Company

New Haven, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

Multiple clinical-stage companies with similar names are developing psychedelic-based therapies and neurostimulation devices for brain health disorders, with programs in Phase 2B trials showing promising data for depression and other psychiatric conditions.

Therapeutic areas: PsychiatryNeurology
Modalities: PsychedelicsSmall moleculeNeuroplastogen
Industry: Biotech

Partnerships

Otsuka Pharmaceutical (with Mindset Pharma)The McQuade Center for Strategic Research and Development (MSRD, Otsuka affiliate)

Beyond the preview

Go deeper on The Mind Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Mind Company.

Explore the full profile